Buprenorphine Sublingual C-Iii 72189-0580-90
- Manufacturer
- Direct_rx
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- September 16, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA078633
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 2 mg/1 |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Selected Package
72189-0580-90Selected90 TABLET in 1 BOTTLE (72189-580-90)
Other packages for this product(1)
60 TABLET in 1 BOTTLE (72189-580-60)